Psoriasis

Atopic Dermatitis

Wound Healing

Skin Grafting

Non-GLP Skin Toxicology

Stroke

Neurodegenerative Diseases (AD’s, PD’s)

Psychopharmacology

CNS-PK

PAH (Pulmonary Arterial Hypertension)

Heart Failure (HFrEF & HFpEF)

IRI (Acute Ischemia Reperfusion Injury)

Gastrointestinal disorders

Metabolic disturbances

Regulatory food toxicology

ETAP-Lab is compliant with
ETHICS
QUALITY
RESPECT

About us

ETAP-Lab is an independent Contract Research Organization (CRO)

a

ETAP-Lab – Preclinical research for confident drug development

Since 1991, ETAP-Lab has been a trusted partner in preclinical research, dedicated to supporting drug development through high-quality pharmacology services and scientific expertise.

Our teams bring extensive experience in both in vitro and in vivo pharmacology. A relevant and translational approach is at the core of our methodology. This is why we were among the first to integrate chronobiology and natural behaviors into our in vivo models, significantly enhancing their predictive value.

We offer standard, validated, and robust models. All our models are customizable, and we can design and validate original, sponsor-specific models upon request. With a rigorous scientific mindset and a strong commitment to reproducibility, ETAP-Lab provides a solid foundation to confidently advance your drug development programs.

Cutting-Edge Platforms

for Translational Research

At the core of our expertise lies a suite of integrated platforms designed to accelerate preclinical research. From advanced in vitro models to state-of-the-art in vivo imaging, behavioral assessments, and biological analyses, our technologies are built to deliver robust, reproducible, and clinically relevant data. Whatever your therapeutic area — neurology, neurovascular, cardiology, or dermatology — our platforms are tailored to support your innovation with precision and scientific rigor.

 

Subscribe to our newsletter

Our News

Member of healthtech networks

The CRO Strok@lliance has been co-created by ETAP-Lab